SFBC International to Host Webcast of Investor Meeting on February 2, 2006

SFBC International, Inc. (NASDAQ:SFCC), a provider of
drug development services to branded pharmaceutical, biotechnology,
generic drug and medical device companies, will host a listen-only
Webcast of its investor meeting at 3:00 p.m. Eastern Time on Thursday,
February 2, 2006.
   The company stated that the primary intent of the meeting is to
allow investors to meet Jeffrey McMullen, the recently appointed chief
executive officer of SFBC. The company will not be providing any
financial information or updates during the meeting. The company
cannot accommodate any additional investors at the meeting location;
therefore, the meeting is being Webcast as a courtesy to those
investors who are not able to attend in person.
   The listen-only Webcast will be available at http://www.sfbci.com.
A replay of the live Webcast will also be available at
http://www.sfbci.com approximately two hours after the live call ends
through March 2, 2006 at 11:59 p.m. Eastern Time.

   About SFBC International, Inc.

   SFBC International, Inc. provides early and late stage clinical
drug development services to branded pharmaceutical, biotechnology,
generic drug and medical device companies around the world. SFBC has
more than 30 offices located in North America, Europe (including
Central and Eastern Europe), South America, Asia, and Australia. In
early clinical development services, SFBC specializes primarily in the
areas of Phase I and early Phase II clinical trials and bioanalytical
laboratory services, including early clinical pharmacology. SFBC also
provides late stage clinical development services globally that focus
on Phase II through IV clinical trials. SFBC also offers a range of
complementary services, including data management and biostatistics,
central laboratory services, medical and scientific affairs,
regulatory affairs and submissions, and clinical IT solutions.
Additional information is available on SFBC's website at
http://www.sfbci.com.